Associations of CKIP-1 and LOX-1 polymorphisms with the risk of type 2 diabetes mellitus with hypertension among Chinese adults

被引:0
|
作者
Xiong, Jiajie [1 ]
Zhang, Liu [2 ]
Chen, Guimei [3 ]
Dong, Pu [1 ]
Tong, Jiani [1 ]
Hua, Long [1 ]
Li, Ning [1 ]
Wen, Liying [1 ]
Zhu, Lijun [1 ]
Chang, Weiwei [1 ]
Jin, Yuelong [1 ]
机构
[1] Wannan Med Coll, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Wuhu 241002, Anhui, Peoples R China
[2] Wuhu Hosp Tradit Chinese Med, Dept Hosp Infect Management Off, Wuhu 241000, Anhui, Peoples R China
[3] Anhui Med Univ, Sch Hlth Management, Hefei 230032, Anhui, Peoples R China
关键词
CKIP-1; LOX-1; Type 2 diabetes mellitus; Hypertension; Polymorphism; PATHWAY;
D O I
10.1007/s00592-023-02175-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Type 2 diabetes mellitus (T2DM) and hypertension are common high-incidence diseases, closely related, and have common pathogenic basis such as oxidative stress. Casein kinase 2 interacting protein-1 (CKIP-1) and low-density lipoprotein receptor (LOX-1) are considered to be important factors affect the level of oxidative stress in the body. The main purpose of this study was to explore the relationship between CKIP-1 (rs6693817 A > T, rs2306235 C > G) and LOX-1 (rs1050283 G > A, rs11053646 C > G) polymorphisms and the risk of hypertension and diabetes, and try to find new candidate genes for diabetes and diabetes with hypertension etiology in Chinese population.Methods 574 T2DM patients and 597 controls frequently matched by age and sex were selected for genotyping of CKIP-1 (rs6693817 A > T, rs2306235 C > G) and LOX-1 gene (rs1050283 G > A, rs11053646 C > G). Logistic regression was used to analyze the correlation between different genotypes and the risk of T2DM and T2DM with hypertension, and the results were expressed as odds ratio (OR) and 95% confidence interval (95% CI).Results We found that the risk of T2DM in the AA + AT genotype of rs6693817 was higher than that in the TT genotype in Chinese population (OR = 1.318, 95%CI: 1.011-1.717, P = 0.041), and the difference was still significant after adjustment (OR = 1.370, 95%CI: 1.043-1.799, P-adjusted = 0.024), the difference of heterozygotes (AT vs TT: OR = 1.374, 95%CI: 1.026-1.840, P-adjusted = 0.033) was statistically significant. But after Bonferroni correction, the significance of the above sites disappeared. And rs6693817 was associated with the risk of T2DM combined with hypertension before and after adjustment in dominant model (OR = 1.424, 95% CI: 1.038-1.954, P = 0.028; OR = 1.460, 95% CI: 1.057-2.015, P-adjusted = 0.021, respectively) and in heterozygote model (OR = 1.499, 95% CI: 1.069-2.102, P = 0.019; OR = 1.562, 95% CI: 1.106-2.207, P-adjusted = 0.011, respectively). However, only the statistical significance of the heterozygous model remained after Bonferroni correction. rs2306235, rs1050283 and rs11053646 were not significantly correlated with T2DM and T2DM combined with hypertension risk (P > 0.05).Conclusions The results suggest that CKIP-1 rs6693817 is related to the susceptibility of Chinese people to T2DM with hypertension, providing a new genetic target for the treatment of diabetes with hypertension with in the future.
引用
收藏
页码:43 / 52
页数:10
相关论文
共 50 条
  • [1] Associations of CKIP-1 and LOX-1 polymorphisms with the risk of type 2 diabetes mellitus with hypertension among Chinese adults
    Jiajie Xiong
    Liu Zhang
    Guimei Chen
    Pu Dong
    Jiani Tong
    Long Hua
    Ning Li
    Liying Wen
    Lijun Zhu
    Weiwei Chang
    Yuelong Jin
    Acta Diabetologica, 2024, 61 : 43 - 52
  • [2] THE SIGNIFICANCE OF OXIDIZED LOW-DENSITY LIPOPROTEINS AND RECEPTORS LOX-1 IN TYPE 2 DIABETES MELLITUS
    Fetlam, Dmitry L.
    Chumachenko, Anastasya G.
    Pisarev, Vladimir M.
    DIABETES MELLITUS, 2024, 27 (06): : 589 - 597
  • [3] Association of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population
    Li, Mu-Peng
    Zhang, Yan-Jiao
    Hu, Xiao-Lei
    Zhou, Ji-Peng
    Yang, Yong-Long
    Peng, Li-Ming
    Qi, Hong
    Yang, Tian-Lun
    Chen, Xiao-Ping
    ONCOTARGET, 2017, 8 (22) : 36545 - 36552
  • [4] CTSG polymorphisms in Chinese children with type 1 diabetes mellitus
    Li, Jiaci
    Zhang, Mingying
    Zhang, Shuyue
    Wang, Rui
    Cai, Yingzi
    Chen, Xiaofang
    Dong, Yan
    Wang, Ping
    Shu, Jianbo
    Lv, Ling
    Cai, Chunquan
    JOURNAL OF TROPICAL PEDIATRICS, 2024, 70 (04)
  • [5] Body Mass Index and Risk for Hypertension of Adults with Type 2 Diabetes Mellitus Body Mass Index and Risk for Hypertension of Adults with Type 2 Diabetes Mellitus
    Prakoso, Agung Tri
    Wahyono, Tri Yunis Miko
    Sibarani, Roy Panusunan
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 843 - 847
  • [6] Association of LOX-1 gene polymorphisms with cerebral infarction in northern Chinese Han population
    Liu, Xu
    Zhu, Rui-Xia
    Li, Lei
    He, Zhi-Yi
    LIPIDS IN HEALTH AND DISEASE, 2014, 13
  • [7] Association of LOX-1 gene polymorphisms with cerebral infarction in northern Chinese Han population
    Xu Liu
    Rui-Xia Zhu
    Lei Li
    Zhi-Yi He
    Lipids in Health and Disease, 13
  • [8] Obesity and its associations with hypertension and type 2 diabetes among Chinese adults age 40 years and over
    He, Yan-Hong
    Jiang, Guo-Xin
    Yang, Yan
    Huang, Hong-Er
    Li, Rui
    Li, Xiao-Ying
    Ning, Guang
    Cheng, Qi
    NUTRITION, 2009, 25 (11-12) : 1143 - 1149
  • [9] Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
    Guo, Xin
    Xiang, Yuanyuan
    Yang, Heng
    Yu, Lijin
    Peng, Xiangdong
    Guo, Ren
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (06) : 572 - 582
  • [10] Association of sleep behaviors, insulin resistance surrogates, and the risk of hypertension in Chinese adults with type 2 diabetes mellitus
    Yao, Xuelin
    Lu, Fangting
    Wang, Zhen
    Miao, Yahu
    Feng, Qing
    Zhang, Yi
    Jiang, Tian
    Tang, Songtao
    Zhang, Nan
    Dai, Fang
    Hu, Honglin
    Zhang, Qiu
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14